Literature DB >> 18355938

A computer program for estimating the re-transformed mean in heteroscedastic two-part models.

Xiao-Hua Zhou1, Hao Cheng.   

Abstract

The population of health care costs is typically skewed, heteroscedastic, and may include zero costs. Without proper accounting for these special distributional features, resulting prediction may be biased, and wrong inferences about the distribution of patients' health care costs may be made. Welsh and Zhou [A.H. Welsh, X.H. Zhou, Estimating the retransformed mean in a heteroscedastic two-part model, J. Stat. Plan. Inference 136 (2006) 860-881] proposed a semi-parametric regression model, which addressed these special features. In this paper we developed a software program to implement this statistical method, which would provide better prediction of health care costs for clinical researchers. Our program computed two mean estimators, their asymptotical standard deviation, confidence interval, and optional bootstrap confidence interval. Our program included user-friendly interactive mode and more efficient and flexible batch mode. It was written in free statistical computing language R and could be run on a wide variety of platforms.

Entities:  

Mesh:

Year:  2008        PMID: 18355938     DOI: 10.1016/j.cmpb.2008.01.004

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  1 in total

1.  Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: results from the population-based KORA Survey in Germany.

Authors:  Andrea Icks; Heiner Claessen; Klaus Strassburger; Michael Tepel; Regina Waldeyer; Nadja Chernyak; Bernd Albers; Christina Baechle; Wolfgang Rathmann; Christa Meisinger; Barbara Thorand; Matthias Hunger; Michaela Schunk; Renée Stark; Ina-Maria Rückert; Annette Peters; Cornelia Huth; Doris Stöckl; Guido Giani; Rolf Holle
Journal:  Diabetes Care       Date:  2013-04       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.